MDPI World AMR Awareness Week 2026
World Antimicrobial Resistance (AMR) Awareness Week, observed annually from 18 to 24 November, highlights the global importance of addressing antimicrobial resistance and preventing the spread of drug-resistant infections. Guided by this year’s theme, “One Health, one action: Prevent AMR now,” the campaign emphasises the shared responsibility of protecting the health of people, animals, plants, and the environment through collective action.
As part of this global initiative, we are pleased to present our World AMR Awareness Week 2026 webinar, bringing together experts to share insights and explore current developments in antimicrobial resistance research. Join us to deepen your understanding of AMR, exchange knowledge, and highlight the importance of collaborative efforts in preventing and tackling antimicrobial resistance.
Date: 23 November 2026, Tuesday
Time: 14:30 (CET) | 21:30 (CST Asia)
Webinar ID: 873 1041 3518
Webinar Secretariat: webinar@mdpi.com
Meet Our Speakers
Associate Professor of Clinical Microbiology, University of Verona; Italy;Paolo Gaibani is an Associate Professor of Clinical Microbiology at the University of Verona and a Clinical Microbiologist at the Azienda Ospedaliera Universitaria Integrata di Verona. His research focuses on antimicrobial resistance, genomic epidemiology, molecular diagnostics, and emerging infectious diseases. He leads and contributes to interdisciplinary research connecting clinical microbiology with translational infectious disease science.
LEPABE, ALiCE, Faculty of Engineering, University of Porto, Portugal;Manuel Simões is a Professor at the Faculty of Engineering in the University of Porto, Portugal, and a researcher at LEPABE/ALiCE. His research focuses on microbial biofilms, antimicrobial resistance, and biotechnology, bridging fundamental science and industrial applications. He has established an internationally recognized research profile, contributing to advances in biofilm control and innovative antimicrobial strategies.
School of Pharmacy, Queen’s University Belfast;Brendan Gilmore is a Professor of Pharmaceutical Microbiology at the School of Pharmacy, Queen’s University Belfast, where he leads the Biofilm Research Group. Research in his group is highly multidisciplinary in nature and aims to understand the mechanistic basis of antimicrobial tolerance exhibited by microbial biofilms, and to develop effective biofilm detection (wound biofilm sensors) and eradication approaches for the treatment of chronic biofilm-mediated infections. Brendan is the Deputy Head of the School of Pharmacy at Queen’s University Belfast, and served as President of the Society for Applied Microbiology (now Applied Microbiology International) from 2000 to 2023. He is the 2026 recipient of the Royal College of Pharmacy Harrison Memorial Medal, which is awarded to an individual whose work has made a substantial, positive and lasting impact on the field of pharmaceutical sciences, and who actively supports the development of juniors and peers. He has published over 165 papers, 20 book chapters and 2 edited books.
Department of Infectious Diseases, Galliera Hospital, Genoa, Italy;Graduated as M.D. in 1994 at the University of Genoa. Infectious Diseases specialist since 1998 (University of Genoa). Worked in the past as Infectious Diseases specialist at Gaslini Hospital and San Martino Hospitals. Associate Professional Officer for WHO in SEARO Office, New Delhi, India (2001-2003) dealing with HIV and TB. Consultant in Infectious Diseases at prison of Genoa since 2003. Consultant in Infectious Diseases at Galliera Hospital since 2006; Director of the Department of Infectious Diseases since 2022. Research interest in HIV/AIDS, TB, PK/PD of antibiotics, Infection Control and Surveillance, antibiotic treatment.
